Spire by St Brides

IRR CEO Vincent Mascolo talks to Alan Green about today’s Zaranou Gold Project update

Vincent Mascolo, CEO of AIM listed IronRidge Resources (AIM: IRR) joins Alan Green of Novus Communications to talk about today’s update on the Zaranou Gold Project on the Ivory Coast. Vincent also covers the latest developments across the company’s other projects including the Ewoyaa Lithium Project, and provides three key takeaway points for investors.

Grand Vision Media Holdings #GVMH – Trading Statement

The directors of GVMH announce the following update. Unaudited revenue for the year ended 31 December 2019 has fallen short of the prior year, at HKD12,034K [2018 : HKD18,026K]. The decline in sales was predominantly as a result of reduced advertising revenues from the OOH cinema sector, and reduced digital marketing revenues. The social unrest […]

ECR Minerals #ECR – AGM Statement

ECR Minerals plc (LON: ECR), the gold exploration and development company focussed on Australia, is pleased to announce that at the Company’s annual general meeting (AGM) held at 9:00am today all resolutions proposed were passed. MARKET ABUSE REGULATIONS (EU) No. 596/2014 The information contained within this announcement is deemed by the Company to constitute inside […]

Tiziana Life Sciences #TILS – Files Patent on Combination of Nanoparticle-Actinomycin D with Anti-Interleukin-6 Receptor Monoclonal Antibody for Treatment of Coronavirus

Tiziana Life Sciences Files Patent on Combination of Nanoparticle-Actinomycin D with Anti-Interleukin-6 Receptor Monoclonal Antibody for Treatment of  Coronaviruses Combination of nanoparticle-Actinomycin D acting as an anti-viral treatment, with an anti-inflammatory agent may present a potential therapeutic option for COVID-19 patients.   New York/London – April 27, 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA) […]

Tiziana Life Sciences #TILS – Acquires Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D for Treatment of Myelodysplastic syndrome and Acute Myeloid Leukemia

New York/London – April 24, 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory, autoimmune and infectious diseases, announced today that it pursuant to an asset purchase agreement it has acquired all of the intellectual property relating to a nanoparticle-based formulation of Actinomycin […]

Irish Independent – Open Orphan subsidiary starts testing drug for treating Covid-19

by Ellie Donnelly A subsidiary of Open Orphan has started testing a drug that could potentially treat Covid-19. Open Orphan is a Europe- focused pharma services company specialising in rare disease and so-called orphan drugs. The tests are being carried out by its London-based subsidiary Hvivo on behalf of its client Nearmedic International. The drug […]